Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage
Avantor, Inc. (NYSE: AVTR) has launched a new biorepository and sample archiving facility in Frankfurt, Germany, enhancing access to samples within 24 hours for researchers. This facility is crucial for the growing demand for clinical trials, especially during the COVID-19 pandemic. Avantor boasts a 40-year heritage in biorepository services, having stored over 100 million research assets without failure. The facility has earned DGNB 'Gold' certification for sustainable construction, underscoring Avantor's commitment to ecological and economic responsibility.
- New biorepository and sample archiving facility in Frankfurt, Germany, improving sample access within 24 hours.
- Supports the increasing demand for clinical trials and research during the COVID-19 pandemic.
- Over 40 years of experience with more than 100 million stored research assets without failures.
- Facility awarded DGNB 'Gold' certification, highlighting commitment to sustainability.
- None.
FRANKFURT, Germany, Nov. 19, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today opened its new biorepository and sample archiving facility in Europe. Strategically located near the international airport in Frankfurt, Germany, the new facility enables researchers to have access to their samples for future research and analysis, or study validation, within 24 hours.
"The number of clinical trials to support research and development (R&D) of therapeutic modalities continues to grow rapidly across the globe. The associated samples and research materials require meticulous care and processing to ensure the validity of the clinical trial," said Christophe Couturier, Executive Vice President, Services at Avantor. "This critical need for speed and agility is only reinforced by the COVID-19 pandemic and the race to ensure safe and efficacious therapies – whether by testing previous discoveries or innovating new ones. Avantor can store samples at the end of a trial, and as vaccine production ramps up, we will be able to support manufacturers with their Bulk Drug Substance storage.
Couturier added, "We're proud of our more than 40-year biorepository heritage, during which Avantor has stored more than 100 million research assets and never failed to return one. It's another example of how Avantor sets science in motion to create a better world."
Avantor's new biorepository and archiving facility in Germany has earned the internationally recognized DGNB "Gold" certification for sustainable construction, which helps to reduce cost intensive risks, while focusing on ecology, economy and sociocultural issues. This new facility complements the Company's U.S. landmark campus located in Leesburg, Va. and its other campus near Nice, France.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
Avantor Regional Media Contact
Kristopher Akana
Director Communications Europe
Avantor
M: +33 (0)6 60 11 12 19
Kristopher.Akana@avantorsciences.com
Global Media Contact
Robert Donohoe
Senior Director, Corporate Communications
Avantor
M: +1-484-688-4730
Robert.Donohoe@avantorsciences.com
View original content:http://www.prnewswire.com/news-releases/avantor-opens-new-biorepository-facility-in-europe-to-support-growing-demand-for-scientific-research-and-clinical-trial-sample-storage-301175201.html
SOURCE Avantor and Financial News
FAQ
What is the purpose of Avantor's new facility in Frankfurt?
When was Avantor's new biorepository facility opened?
How does Avantor support clinical trials with its new facility?
What notable recognition has Avantor's facility received?
